Hess Corporation
—- Market cap
- —
- Debt
- +$8.60B
- Cash
- −$1.17B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HES stock price vs EVH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EVH's multiple
Needs EVH P/E.
Implied fair value · at HES's multiple
Needs EPS (TTM) is negative, HES P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HES FY 2024 (ended Dec 31, 2024) · EVH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HESS CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Evolent Health, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.77x
2.34x
Net debt / EBITDA
Leverage against operating earnings
1.55x
-2.11x
Cash and equivalents
Liquid reserves on the balance sheet
$1.17B
$151.86M
Total debt
Interest-bearing obligations outstanding
$8.60B
$970.54M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Exxon Mobil Corporation
HES vs XOM
Chevron Corporation
HES vs CVX
VALERO ENERGY CORP/TX
HES vs VLO
Marathon Petroleum Corp
HES vs MPC
Cigna Group
HES vs CI
MOLINA HEALTHCARE, INC.
HES vs MOH
Teladoc Health, Inc.
HES vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
HES vs CLOV
UNITEDHEALTH GROUP INC
HES vs UNH
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.